Patterns of tobacco exposure before and during pregnancy

Marlene Anderka; Paul A Romitti; Lixian Sun; Charlotte Druschel; Suzan Carmichael; Gary Shaw; National Birth Defects Prevention Study

doi:10.3109/00016341003692261

Back

Patterns of tobacco exposure before and during pregnancy

Journal article

Open access

Peer reviewed

Patterns of tobacco exposure before and during pregnancy

Marlene Anderka, Paul A Romitti, Lixian Sun, Charlotte Druschel, Suzan Carmichael, Gary Shaw and National Birth Defects Prevention Study

Acta obstetricia et gynecologica Scandinavica, Vol.89(4), pp.505-514

2010

DOI: 10.3109/00016341003692261

PMCID: PMC6042858

PMID: 20367429

Files and links (1)

url

https://doi.org/10.3109/00016341003692261View

Published (Version of record) Open Access

Abstract

To describe maternal exposure to tobacco in the three months before conception and throughout pregnancy, examine risk factors associated with tobacco exposure in pregnancy and smoking cessation, assess use of pharmacotherapy for smoking cessation and evaluate birth outcomes by smoking status. A cohort of women from a multi-site United States study were asked retrospectively about their exposure to tobacco. The study population was comprised of 4,667 mothers of non-malformed control infants who participated in the National Birth Defects Prevention Study from 1997 to 2003. Using computer-assisted telephone interview responses from this population-based sample, we assessed patterns of maternal smoking and exposure to environmental tobacco smoke (ETS) as well as use of pharmacotherapy for quitting smoking during pregnancy. Overall, 961 (20.6%) mothers reported any smoking and 1,401 (30.0%) reported any exposure to ETS at home or work during the three months before conception through pregnancy. Of the 961 smokers, 512 (53.3%) reportedly quit smoking before or during pregnancy, including 379 (74% of quitters) in the first trimester, and 420 (43.7%) continued to smoke throughout the pregnancy. Only 2.1% of smokers reportedly used pharmacotherapy to quit smoking anytime from three months before conception through pregnancy. Low birthweight and preterm delivery rates were lowest among offspring of non-smokers and highest in offspring of those who continued to smoke throughout pregnancy. About one-half of mothers who reported preconceptional smoking quit before or during pregnancy. Use of pharmacotherapy to quit smoking during pregnancy was not common.

Pregnancy

Infant, Low Birth Weight

United States - epidemiology

Fertilization

Humans

Dopamine Uptake Inhibitors - therapeutic use

Smoking Cessation - statistics & numerical data

Tobacco Smoke Pollution - statistics & numerical data

Premature Birth - epidemiology

Maternal Exposure - statistics & numerical data

Smoking Cessation - methods

Smoking - epidemiology

Adult

Female

Continental Population Groups - statistics & numerical data

Pregnancy Trimesters

Infant, Newborn

Bupropion - therapeutic use

Cohort Studies

Details

Title: Subtitle: Patterns of tobacco exposure before and during pregnancy
Creators: Marlene Anderka - Massachusetts Department of Public Health, Massachusetts Center for Birth Defects Research and Prevention, Boston, MA 02108, USA. marlene.anderka@state.ma.us
Paul A Romitti
Lixian Sun
Charlotte Druschel
Suzan Carmichael
Gary Shaw
National Birth Defects Prevention Study
Resource Type: Journal article
Publication Details: Acta obstetricia et gynecologica Scandinavica, Vol.89(4), pp.505-514
Publisher: United States
DOI: 10.3109/00016341003692261
PMID: 20367429
PMCID: PMC6042858
ISSN: 1600-0412
eISSN: 1600-0412
Grant note: U01 DD000492 / NCBDD CDC HHS U50/CCU113247 / PHS HHS U50 DD113247 / NCBDD CDC HHS
Language: English
Date published: 2010
Academic Unit: Epidemiology; Biostatistics
Record Identifier: 9983995003702771

Metrics

50 Record Views

44 Times Cited - Web of Science

See more details